R01 AG030482/AG/NIA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	3
2009	3
2010	5
2011	4
2012	3
2013	1
2015	1
2024	0

1

Nuclear receptors as therapeutic targets for Alzheimer's disease.

Mandrekar-Colucci S, Landreth GE. Mandrekar-Colucci S, et al. Expert Opin Ther Targets. 2011 Sep;15(9):1085-97. doi: 10.1517/14728222.2011.594043. Epub 2011 Jul 1. Expert Opin Ther Targets. 2011. PMID: 21718217 Free PMC article. Review.

2

Inflammation, microglia, and Alzheimer's disease.

Cameron B, Landreth GE. Cameron B, et al. Neurobiol Dis. 2010 Mar;37(3):503-9. doi: 10.1016/j.nbd.2009.10.006. Epub 2009 Oct 13. Neurobiol Dis. 2010. PMID: 19833208 Free PMC article. Review.

3

Microglia and inflammation in Alzheimer's disease.

Mandrekar-Colucci S, Landreth GE. Mandrekar-Colucci S, et al. CNS Neurol Disord Drug Targets. 2010 Apr;9(2):156-67. doi: 10.2174/187152710791012071. CNS Neurol Disord Drug Targets. 2010. PMID: 20205644 Free PMC article. Review.

4

PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease.

Landreth G, Jiang Q, Mandrekar S, Heneka M. Landreth G, et al. Neurotherapeutics. 2008 Jul;5(3):481-9. doi: 10.1016/j.nurt.2008.05.003. Neurotherapeutics. 2008. PMID: 18625459 Free PMC article. Review.

5

The role of microglia in amyloid clearance from the AD brain.

Lee CY, Landreth GE. Lee CY, et al. J Neural Transm (Vienna). 2010 Aug;117(8):949-60. doi: 10.1007/s00702-010-0433-4. Epub 2010 Jun 15. J Neural Transm (Vienna). 2010. PMID: 20552234 Free PMC article. Review.

6

The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications.

Jiang Q, Heneka M, Landreth GE. Jiang Q, et al. CNS Drugs. 2008;22(1):1-14. doi: 10.2165/00023210-200822010-00001. CNS Drugs. 2008. PMID: 18072811 Review.

7

Apolipoprotein E promotes β-amyloid trafficking and degradation by modulating microglial cholesterol levels.

Lee CY, Tse W, Smith JD, Landreth GE. Lee CY, et al. J Biol Chem. 2012 Jan 13;287(3):2032-44. doi: 10.1074/jbc.M111.295451. Epub 2011 Nov 30. J Biol Chem. 2012. PMID: 22130662 Free PMC article.

8

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.

Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE. Cramer PE, et al. Science. 2012 Mar 23;335(6075):1503-6. doi: 10.1126/science.1217697. Epub 2012 Feb 9. Science. 2012. PMID: 22323736 Free PMC article.

9

Response to comments on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

Landreth GE, Cramer PE, Lakner MM, Cirrito JR, Wesson DW, Brunden KR, Wilson DA. Landreth GE, et al. Science. 2013 May 24;340(6135):924-g. doi: 10.1126/science.1234114. Science. 2013. PMID: 23704556 Free PMC article.

10

Sensory network dysfunction, behavioral impairments, and their reversibility in an Alzheimer's β-amyloidosis mouse model.

Wesson DW, Borkowski AH, Landreth GE, Nixon RA, Levy E, Wilson DA. Wesson DW, et al. J Neurosci. 2011 Nov 2;31(44):15962-71. doi: 10.1523/JNEUROSCI.2085-11.2011. J Neurosci. 2011. PMID: 22049439 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

17 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year